Cargando…

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients

BACKGROUND: The diagnosis of sepsis is challenging and there is an unmet need for sensitive and specific diagnostic and prognostic biomarkers. Following activation of macrophages and monocytes, the haptoglobin-haemoglobin receptor (CD163) and the mannose receptor (MR) are shed into the circulation (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjærgaard, Anders G., Rødgaard-Hansen, Sidsel, Dige, Anders, Krog, Jan, Møller, Holger J., Tønnesen, Else
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956910/ https://www.ncbi.nlm.nih.gov/pubmed/24637679 http://dx.doi.org/10.1371/journal.pone.0092331

Ejemplares similares

Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer
por: Ding, Dongbing, et al.
Publicado: (2017)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2017)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

Regular Training Increases sTWEAK and Its Decoy Receptor sCD163–Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
por: Schönbauer, Robert, et al.
Publicado: (2020)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Clinical significance of sCD163 and its possible role in asthma
por: Zhi, Yue, et al.
Publicado: (2017)

The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids
por: Thomsen, Henrik H, et al.
Publicado: (2013)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT
por: De Vlieger, Greet, et al.
Publicado: (2019)

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
por: Silva, Ricardo Luís Louzada, et al.
Publicado: (2017)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
por: Stuhr, Liva K., et al.
Publicado: (2023)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015)

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors
por: Castley, Alison, et al.
Publicado: (2016)

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
por: Bach, Ermina, et al.
Publicado: (2019)

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023)

The Leukocyte VCS Parameters Compared with Procalcitonin, Interleukin-6, and Soluble Hemoglobin Scavenger Receptor sCD163 for Prediction of Sepsis in Patients with Cirrhosis
por: Guo, Fan, et al.
Publicado: (2019)

Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis
por: Qian, Shushu, et al.
Publicado: (2020)

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
por: Marocco, Raffaella, et al.
Publicado: (2022)

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
por: Kaji, Kosuke, et al.
Publicado: (2020)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin Scavenging
por: Thomsen, Jens Haugbølle, et al.
Publicado: (2013)

Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals
por: Yadav, Anjana, et al.
Publicado: (2019)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Soluble CD163, a Product of Monocyte/Macrophage Activation, Is Inversely Associated with Haemoglobin Levels in Placental Malaria
por: Chua, Caroline Lin Lin, et al.
Publicado: (2013)

Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
por: Graversen, Jonas H, et al.
Publicado: (2012)

Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study
por: Su, Longxiang, et al.
Publicado: (2012)

Systemic corticosteroid therapy augments ex vivo release of sCD163 by peripheral blood monocytes of asthmatic patients
por: Bernatowicz, Paweł L., et al.
Publicado: (2020)

The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis
por: Volfovitch, Yuval, et al.
Publicado: (2022)

Mouse CD163 deficiency strongly enhances experimental collagen-induced arthritis
por: Svendsen, Pia, et al.
Publicado: (2020)

Preliminary Study of sCD14 and sCD163 as Predictors of Disease Severity and ICU Admission in COVID-19: Relation to Hematological Parameters, Blood Morphological Changes and Inflammatory Biomarkers
por: Attia, Hend, et al.
Publicado: (2023)

Effect of compounds on the purification and antibody preparation of the extracellular domain fragment of the receptor CD163
por: Cao, Zong-Xi, et al.
Publicado: (2011)

CD163 Antibodies Inhibit PRRSV Infection via Receptor Blocking and Transcription Suppression
por: Xu, Huiling, et al.
Publicado: (2020)

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls
por: Mosepele, Mosepele, et al.
Publicado: (2017)

Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages
por: Zhang, Ting, et al.
Publicado: (2020)

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ftkqqfj4r84sdhascoepuo589g